Jaebong Jang
Seoul National University(KR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Asymmetric Synthesis and Catalysis, Radiopharmaceutical Chemistry and Applications, Cancer therapeutics and mechanisms
Most-Cited Works
- → Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors(2016)858 cited
- → A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader(2017)433 cited
- → Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor(2019)321 cited
- → An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer(2022)150 cited
- → Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations(2020)135 cited
- → Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein(2018)97 cited
- → A Review of the Pharmacological Activities and Recent Synthetic Advances of γ-Butyrolactones(2021)91 cited
- → Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors(2019)88 cited
- → Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors(2022)82 cited
- → A synthetic cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells(2015)78 cited